Serina Therapeutics, Inc.
Symbol: SER (NYSE)
5.11
▼ (-1.64%) -0.085
Company Description:
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.
Key Stats
- Today's Open: $5.19
- Today's High: $5.345
- Today's Low: $5.075
- Today's Volume: 6.48K
- Yesterday Close: $5.19
- Yesterday High: $5.2488
- Yesterday Low: $5.02
- Yesterday Volume: 12.64K
- Last Min Volume: 7
- Last Min High: $5.105
- Last Min Low: $5.105
- Last Min VWAP: $5.105
Company Profile
- Name: Serina Therapeutics, Inc.
- Website: https://www.serinatherapeutics.com
- Listed Date: 2024-03-27
- Location: HUNTSVILLE, AL
- Market Status: Active
- CIK Number: 0001708599
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $53.20M
- Round Lot: 100
- Outstanding Shares: 10.25M
- Asset Type: CS
RECENT FILINGS FOR SER
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-09 | 8-K | View |
| 2025-08-27 | 4 | View |
| 2025-08-25 | 8-K | View |
| 2025-08-22 | 8-K | View |
| 2025-08-20 | 4 | View |
| 2025-08-14 | 4 | View |
| 2025-08-11 | 8-K | View |
| 2025-08-11 | 10-Q | View |
| 2025-08-06 | 4 | View |
| 2025-07-30 | 4 | View |
| 2025-07-29 | 4 | View |
| 2025-07-29 | 8-K | View |
| 2025-07-22 | 4 | View |
| 2025-07-17 | 4 | View |
| 2025-07-09 | 4 | View |
| 2025-07-02 | 4 | View |
| 2025-07-01 | 8-K | View |
| 2025-06-30 | 144 | View |
| 2025-06-17 | 4 | View |
| 2025-06-17 | 3 | View |
Latest News on SER